BioSpace News Archive

Business

Former FDA Reviewer Iftekhar Mahmood, Ph.D., Joins Nuventra Pharma Sciences as Senior Consultant, Clinical Pharmacology and Pharmacometrics

Nuventra Pharma Sciences is pleased to announce the addition of Iftekhar Mahmood, Ph.D., to its growing team of experienced consultants. Dr. Mahmood has more than 25 years of clinical pharmacology experience at the FDA..

October 28, 2019
·
2 min read
Business

Castle Biosciences to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 11, 2019

Castle Biosciences, Inc. announced that it will release its financial results for the third quarter ended September 30, 2019, after the close of market on Monday, November 11, 2019.

October 28, 2019
·
2 min read
Job Trends

Castle Biosciences Presents Second Study Confirming Ability of DecisionDx-Melanoma to Inform Sentinel Lymph Node Biopsy Decisions at the 8th International Congress on Cancer Metastasis

Castle Biosciences, Inc. announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform decisions of whether to discuss or recommend the sentinel lymph node biopsy, a surgical procedure used to provide additional prognostic information.

October 28, 2019
·
7 min read
Business

Kraig Biocraft Laboratories Spider Silk Facility to Break Corporate Production Capacity Records within First Months of Operation

Kraig Biocraft Laboratories, Inc., the leading developer of spider silk based fibers, announced that operations at its Vietnamese production facility, which just formally kicked off earlier this month, are on track to set new production capacity records for the Company.

October 28, 2019
·
3 min read
Business

Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 4, 2019

Deciphera Pharmaceuticals, Inc. announced that it will report its third quarter 2019 financial results on Monday, November 4, 2019.

October 28, 2019
·
2 min read
Business

Walgreens Boots Alliance Reports Fiscal Year 2019 Results in Line with Guidance

Company Making Progress on Strategic Priorities to Deliver Long-Term Growth

October 28, 2019
·
18 min read
Deals

ISS Recommends Shareholders Vote on the GREEN Consent Card for Election of Velan Nominees and Removal of Progenics CEO

Recommends Removal of CEO Mark Baker, Citing ‘Past Questionable Actions’ and ‘Poor Performance’ and Advises ‘DO NOT VOTE’ on the WHITE card

October 28, 2019
·
7 min read
Business

ZyVersa Therapeutics’ CEO, Stephen C. Glover to Present at the Inaugural Inflammasome Therapeutics Summit on October 30th, 2019

ZyVersa Therapeutics, Inc. is pleased to announce that Stephen C. Glover, ZyVersa’s Co-Founder, Chief Executive Officer, and President, is an invited speaker at the inaugural Inflammasome Therapeutics Summit to be held in Boston on October 29-31, 2019.

October 28, 2019
·
3 min read
Business

VIVUS Announces Departures of Eric W. Roberts and Allan L. Shaw from Board of Directors

VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, announced today that Eric W. Roberts and Allan L. Shaw have resigned from its Board of Directors and all of its committees in order to increase their focus on other personal business interests.

October 28, 2019
·
2 min read
Business

Bhang Inc. Announces Senior Management Changes

Bhang Inc. (“Bhang” or the “Company”) (CSE: BHNG) (OTCQX: BHNGF), a global cannabis company with an extensive, award-winning portfolio of products, announced today that Jamie Pearson, Bhang’s COO, will assume the role of Interim President, replacing Tom Stein

October 28, 2019
·
5 min read